Table 2.
Clinical characteristics of men with negative multiparametric prostate MRI (PI-RADS 1–2).
| No cancer | insPCa | sPCa | |
|---|---|---|---|
| n | 50 | 11 | 5 |
| Age (years) | 62.6 (53.2–74.0) | 64.7 (55.1–74.1) | 67.5 (64.3–72.0) |
| PSA (ng/ml) | 6.3 (0.8–15.5) | 6.2 (4.2–10.0) | 7.4 (5.5–10.1) |
| PSAD (ng/ml/cc) | 0.1 (0.03–0.32) | 0.10 (0.04–0.4) | 0.20 (0.1–0.44) |
| Prostate volume (cc) | 61.5 (31.0–203.0) | 54.0 (25.0–169.0) | 39.0 (23.0–57.0) |
| DRE, n (%) | |||
| Normal | 37 (74) | 10 (90.9) | 3 (60.0) |
| Abnormal | 6 (12) | 0 (0.0) | 2 (40.0) |
| NA | 7 (14) | 1 (9.1) | 0 (0.0) |
The descriptive statistics are median (range) for continuous values and n (%) for categorical values.
insPCa, insignificant prostate cancer; sPCa, significant prostate cancer; PSA, prostate-specific antigen; PSAD, prostate-specific antigen density; DRE, digital rectal examination; NA, not available.